Nocturnal Enuresis
Conditions
Keywords
spinal magnetic stimulation, nocturnal enuresis, neuromodulation
Brief summary
A prospective randomized trial to study the effect of spinal magnetic stimulation versus posterior tibial neuromodulation in the treatment of monosymptomatic nocturnal enuresis.
Detailed description
Nocturnal enuresis is defined as nighttime bedwetting in children aged five years or older.Currently available treatment options for nocturnal enuresis include medication, wetting alarms, lifestyle changes, sacral magnetic stimulation, and posterior tibial neurmodulation. Magnetic stimulation is a valid method for stimulation of sacral as functional electrical stimulation. It generates a more powerful and deeper electrical field than that produced by conventional electrical stimulators. So, magnetic stimulation could be considered an attractive form of electrical therapy, being relatively painless, non-invasive and free from side effects.Peripheral neuromodulation is the modulation of the physiologic behavior of the nerve by electrical stimulation. Posterior tibial neuromodulation is an effective method in treatment of urinary incontinence
Interventions
OTHERRehabilitation
rehabilitation sessions using spinal magnetic stimulation or neuromodulation
Sponsors
University of Alexandria
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
5 Years to 30 Years
Healthy volunteers
No
Inclusion criteria
* All subjects were diagnosed as patients with MNE according to the Diagnostic and statistical manual of mental disorders, 4th revised edition (DSM-IV) (American Psychiatric Association's DSM-IV, 1994): bed-wetting ≥3 times a week; lasting more than 6 months; can control urination during the day but cannot control urination after falling asleep.
Exclusion criteria
* \- Patients younger than 5 years old. * Patients who have any abnormality in blood or urine biochemistry. * Patients with other urinary symptoms. * Patients with neurological or endocrinal abnormalities (such as cerebral palsy, spinal cord lesion, peripheral neuropathy or diabetes mellitus)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Frequency of bed wetting | one month | Number of bed wettings/ week |
| Visual analogue scale to determine how much the enuresis affected his/her life. | three months | Visual analogue scale from zero to ten (zero indicates no effect, 10 indicates severe bothersome |
Countries
Egypt
Contacts
Primary ContactNehad ElShatby
Outcome results
None listed